These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New frontiers in therapy of malignant gliomas. Puduvalli VK; Yung AW Forum (Genova); 1998; 8(3):261-9. PubMed ID: 9755291 [TBL] [Abstract][Full Text] [Related]
4. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. Hargrave D Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006 [TBL] [Abstract][Full Text] [Related]
5. Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies. Argyriou AA; Antonacopoulou A; Iconomou G; Kalofonos HP Crit Rev Oncol Hematol; 2009 Mar; 69(3):199-210. PubMed ID: 18602834 [TBL] [Abstract][Full Text] [Related]
6. Editorial review: targets for glioma treatment: from bench to bedside. Sanson M Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046 [TBL] [Abstract][Full Text] [Related]
7. Molecularly targeted therapies for malignant gliomas: advances and challenges. Penas-Prado M; Gilbert MR Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929 [TBL] [Abstract][Full Text] [Related]
8. Multimodal treatment of adult intracranial gliomas. Shapiro S; Mealey J; Kay S Indiana Med; 1991 Apr; 84(4):246-50. PubMed ID: 2037772 [TBL] [Abstract][Full Text] [Related]
10. [Molecular control of the cellular cycle and apoptosis: new treatments for gliomas]. Fueyo J; Gómez-Manzano C Neurologia; 1998; 13(7):349-55. PubMed ID: 9810797 [TBL] [Abstract][Full Text] [Related]
11. Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas. Mason WP; Cairncross JG Neurology; 2008 Jul; 71(5):365-73. PubMed ID: 18663182 [TBL] [Abstract][Full Text] [Related]
12. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301 [TBL] [Abstract][Full Text] [Related]
13. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials. Quant EC; Wen PY Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556 [TBL] [Abstract][Full Text] [Related]
14. Glioma stem cell signaling: therapeutic opportunities and challenges. Dietrich J; Diamond EL; Kesari S Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003 [TBL] [Abstract][Full Text] [Related]
15. Spectrum of pediatric gliomas: implications for the development of future therapies. Pytel P Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S51-60. PubMed ID: 18076319 [TBL] [Abstract][Full Text] [Related]
16. [Treatment modalities for malignant gliomas with reference to their pathophysiology]. Kobayashi S; Takakura K Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392 [TBL] [Abstract][Full Text] [Related]
17. Cell- and peptide-based immunotherapeutic approaches for glioma. Yamanaka R Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264 [TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibitors in children with malignant gliomas. Herrington B; Kieran MW Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732 [TBL] [Abstract][Full Text] [Related]